Fractionated Dosing Optimizes CAR T-Cell Therapy in Adult Relapsed/Refractory ALL

Slideset - Fractionated dosing of CTL019 minimized CRS-related toxicity and maintained high response rates in patients with relapsed/refractory CD19+ ALL.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research